Famvir (famciclovir) Tablets, Novartis NDA 20-363/SLR-019 3/27/01 5/1/01 Famvir (famciclovir) Tablets, 125mg, 250mg, & 500mg SmithKline Beecham NDA 20-363/S-010/S-014/S-016 6/12/98 1/6/99 Famvir Indication: for the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients. Famvir (famciclovir) Tablets Novartis NDA 20-363/SLR-019

For the most up-to-date approval information, please locate this API using the drug index. For industry specific content, please visit USActives.com.